Home/Pipeline/Thoracic Oncology Consortium

Thoracic Oncology Consortium

Lung and Thoracic Cancers

UnknownActive

Key Facts

Indication
Lung and Thoracic Cancers
Phase
Unknown
Status
Active
Company

About Criterium

Criterium is a long-established, privately-held CRO that has carved out a specialized niche in oncology clinical research through its innovative Oncology Consortia model. The company combines hands-on operational expertise with technology solutions like interactive voice/web response (IVR/IWR) and ePRO to manage complex trials efficiently. Its core strategy involves forming disease-specific consortia with top-tier universities and cancer centers, enabling rapid patient recruitment and high-quality data generation for pharmaceutical and biotech sponsors. While primarily a service provider, its deep integration into therapeutic development gives it significant insight into the oncology pipeline landscape.

View full company profile